Marshall Wace
CTKB icon

Marshall Wace’s Cytek Biosciences CTKB Stock Holding History

Marshall Wace’s Portfolio CTKB Stock Details CTKB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-134,286
Closed -$466K – 3046
2025
Q3 		$466K Sell
134,286
-127,066
-49% -$477K ﹤0.01% 2258
2025
Q2 		$889K Buy
+261,352
New +$871K ﹤0.01% 1905
2024
Q2 		– Sell
-68,591
Closed -$460K – 2626
2024
Q1 		$460K Buy
+68,591
New +$543K ﹤0.01% 1959
2022
Q3 		– Sell
-54,096
Closed -$582K – 3434
2022
Q2 		$582K Buy
+54,096
New +$538K ﹤0.01% 2723
2022
Q1 		– Sell
-7,160
Closed -$117K – 3477
2021
Q4 		$117K Buy
+7,160
New +$150K ﹤0.01% 3343

Other funds holding CTKB

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Topline Capital Management Santa Monica, California $605M AUM 26.24% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return